These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 640479)

  • 21. [Contribution to the aetiology of "reversible hepatic dysfunction" (Stauffer's syndrome) associated with renal tumours].
    Girmann G; Gratzl M; Pees H; Seebach HB; Scheurlen PG
    Dtsch Med Wochenschr; 1975 Mar; 100(10):480-4. PubMed ID: 1112200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune system in gynecologic malignancies.
    Barber HR; Dorsett BH
    Mt Sinai J Med; 1980; 47(5):539-49. PubMed ID: 6969360
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
    Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
    [No Abstract]   [Full Text] [Related]  

  • 24. Regan isoenzyme in ovarian cancer: reappraisal with a new assay method.
    Chen SS; Hsu D
    Cancer Detect Prev; 1985; 8(4):465-9. PubMed ID: 4053108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymes and isoenzymes in different body tissue and fluids in benign and malignant gynecological tumors.
    Menaché R; Rubinstein I; Israel S; Halbrecht I
    Isr J Med Sci; 1977 Aug; 13(8):848-51. PubMed ID: 893068
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological markers in gynecologic cancers. An overview.
    Dini MM; Miller M
    IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of the concentration and origin of antigens on leukocyte migration in women with malignant gynecologic tumors].
    Tosner J; Fixa B
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(2):121-7. PubMed ID: 6969923
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigens, enzymes and hormones. Their roles as tumor markers in gynecologic neoplasia.
    Fenoglio CM
    Diagn Gynecol Obstet; 1980; 2(1):33-42. PubMed ID: 6162629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histochemical examination of alkaline phosphatase in female genital tumors].
    KRIZ J
    Cesk Gynekol; 1956 Nov; 21(6):361-8. PubMed ID: 13396787
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
    Ulsperger E; Karrer K
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():33-43. PubMed ID: 3074225
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of intratumor heterogeneity by simultaneous multiparameter flow cytometric analysis with enzyme and DNA markers.
    Haskill S; Kivinen S; Nelson K; Fowler WC
    Cancer Res; 1983 Mar; 43(3):1003-9. PubMed ID: 6130836
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3 simultaneous primary malignant tumors in the female genitalia].
    Chylak V; Krusić J
    Jugosl Ginekol Opstet; 1983; 23(3-4):83-5. PubMed ID: 6664108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers for ovarian cancer: regan isoenzyme and other glycoproteins.
    Fishman WH; Raam S; Stolbach LL
    Semin Oncol; 1975 Sep; 2(3):211-6. PubMed ID: 63996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The localization and differential diagnosis of benign and malignant gynaecological tumours in the axial computer assisted tomogram (author's transl)].
    Langer M; Langer R; Schumacher KA; Maier W
    Geburtshilfe Frauenheilkd; 1981 Aug; 41(8):551-5. PubMed ID: 6912169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ca 125 values in inflammatory adnexal disease and endometriosis].
    Sonsalla R; Kuss E; Zander J
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):499-500. PubMed ID: 3305148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of leukocyte alkaline phosphatase determinations.
    Kaplow LS
    Rev Roum Med Intern; 1973; 10(5):365-72. PubMed ID: 4797456
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-homogeneity of serum alkaline phosphatase activity in certain diseases of the liver and bile ducts investigated by polyacrylamide electrophoresis.
    Gabryś K
    Pol Med Sci Hist Bull (1973); 1975; 15(2):161-5. PubMed ID: 1223817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of serum alkaline phosphatase by murine monoclonal antibodies against human osteosarcoma cells.
    Tanaka C; Yamamuro T; Masuda T; Tanaka H; Matsumoto M; Kotoura Y; Tsuji T; Toguchida J; Miyama-Inaba M; Ueda M
    Cancer Res; 1986 Sep; 46(9):4853-7. PubMed ID: 3524820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.